Stockscreener 앱 받기
2.17
3.56%
-0.08
전일 마감가:
$2.25
열려 있는:
$2.21
하루 거래량:
2.21M
Relative Volume:
1.36
시가총액:
$345.32M
수익:
$10.00M
순이익/손실:
$-29.47M
주가수익비율:
-10.85
EPS:
-0.2
순현금흐름:
$-21.55M
1주 성능:
+5.34%
1개월 성능:
+17.93%
6개월 성능:
-21.94%
1년 성능:
-41.82%
1일 변동 폭
$2.17
$2.31
1주일 범위
$2.015
$2.37
52주 변동 폭
$1.47
$3.88
Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile
명칭
Mereo Biopharma Group Plc Adr
전화
4403330237300
주소
ONE CAVENDISH PLACE, LONDON
MREO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MREO
Mereo Biopharma Group Plc Adr
|
2.17 | 358.05M | 10.00M | -29.47M | -21.55M | -0.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-27 | 개시 | JP Morgan | Overweight |
| 2024-12-06 | 개시 | Jefferies | Buy |
| 2024-06-13 | 개시 | Robert W. Baird | Outperform |
| 2023-10-13 | 재개 | BTIG Research | Buy |
| 2022-08-12 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-05-05 | 개시 | BTIG Research | Buy |
| 2021-04-05 | 개시 | Needham | Buy |
모두보기
Mereo Biopharma Group Plc Adr 주식(MREO)의 최신 뉴스
Mereo BioPharma Group plcSponsored ADR $MREO Shares Bought by Frazier Life Sciences Management L.P. - MarketBeat
683 Capital Management LLC Decreases Stock Holdings in Mereo BioPharma Group plc – Sponsored ADR $MREO - Defense World
Traders Purchase High Volume of Put Options on Mereo BioPharma Group (NASDAQ:MREO) - Defense World
Mereo BioPharma Group Target of Unusually Large Options Trading (NASDAQ:MREO) - MarketBeat
Investors Buy High Volume of Call Options on Mereo BioPharma Group (NASDAQ:MREO) - Defense World
Mereo BioPharma Group Target of Unusually High Options Trading (NASDAQ:MREO) - MarketBeat
It makes sense and dollars to buy Mereo Biopharma Group Plc ADR (MREO) stock - setenews.com
Baird names Mereo BioPharma stock a Fresh Pick ahead of OI data - Investing.com UK
This trade activity should not be overlooked: Mereo Biopharma Group Plc ADR (MREO) - Setenews
Mereo BioPharma Group plc (MREO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Cantor Fitzgerald Analysts Raise Earnings Estimates for MREO - MarketBeat
Equities Analysts Issue Forecasts for MREO FY2025 Earnings - Defense World
A better buy-in window may exist right now for Mereo Biopharma Group Plc ADR (MREO) - Setenews
Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Wall Street analysts’ outlook for Mereo Biopharma Group Plc ADR (MREO) - Setenews
FY2025 EPS Forecast for Mereo BioPharma Group Cut by Analyst - Defense World
Leerink Partnrs Has Negative Forecast for MREO Q4 Earnings - MarketBeat
Leerink Partnrs Issues Negative Forecast for MREO Earnings - Defense World
A new trading data show Mereo Biopharma Group Plc ADR (MREO) is showing positive returns. - setenews.com
[8-K] Mereo BioPharma Group plc Reports Material Event | MREO SEC FilingForm 8-K - Stock Titan
Mereo Biopharma Group Plc ADR (MREO) looking to reclaim success with recent performance - Setenews
Tangible book value per share of Mereo BioPharma Group plc Sponsored ADR – HAN:MAH0 - TradingView
Aberdeen Group plc Has $8.21 Million Stock Position in Mereo BioPharma Group plcSponsored ADR $MREO - MarketBeat
Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Given Average Rating of “Buy” by Brokerages - Defense World
An analyst sees good growth prospects for Chime Financial Inc (CHYM) - Setenews
Atle Fund Management AB Has $2.07 Million Stock Position in Mereo BioPharma Group plcSponsored ADR $MREO - MarketBeat
Goldman Sachs Group Inc. Raises Stake in Mereo BioPharma Group plc – Sponsored ADR $MREO - Defense World
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), KalVista Pharmaceuticals (KALV) and Argenx Se (ARGX) - The Globe and Mail
Adage Capital Partners GP L.L.C. Has $3.83 Million Stock Position in Mereo BioPharma Group plcSponsored ADR $MREO - MarketBeat
Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Given Average Recommendation of “Buy” by Brokerages - Defense World
Frazier Life Sciences Management L.P. Increases Stock Holdings in Mereo BioPharma Group plcSponsored ADR $MREO - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plcMREO - cnhinews.com
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - FinancialContent
Pomerantz LLP investigates Mereo BioPharma securities fraud claims. - AInvest
JPMorgan Chase & Co. Issues Positive Forecast for Mereo BioPharma Group (NASDAQ:MREO) Stock Price - Defense World
Mereo BioPharma Group plc investigated for securities fraud and unlawful practices. - AInvest
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - GlobeNewswire Inc.
FY2026 EPS Estimates for MREO Lifted by Cantor Fitzgerald - Defense World
Oklahoma City NewsThe Oklahoman - Markets Financial Content
Leerink Partnrs Has Negative Outlook for MREO Q3 Earnings - Defense World
Analysts Offer Predictions for MREO Q3 Earnings - Defense World
Mereo BioPharma Group faces securities fraud investigation. - AInvest
Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Receives Average Rating of “Buy” from Analysts - Defense World
Mereo BioPharma ADR earnings beat, revenue fell short of estimates By Investing.com - Investing.com Nigeria
Mereo Biopharma Group Plc Adr (MREO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):